Related Experiment Video

Updated: Dec 8, 2025

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.4K

Nanotechnology for multimodality treatment of cancer

Xiao-Ying Zhang, Pei-Ying Zhang

    Oncology Letters
    |September 24, 2020
    PubMed

    Abstract:

    [This retracts the article DOI: 10.3892/ol.2016.5322.].

    More Related Videos

    Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
    09:02

    Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

    Published on: September 27, 2024

    3.0K
    Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
    07:25

    Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment

    Published on: March 1, 2024

    2.8K

    Related Experiment Videos

    Last Updated: Dec 8, 2025

    Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
    09:01

    Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

    Published on: May 22, 2020

    3.4K
    Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
    09:02

    Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

    Published on: September 27, 2024

    3.0K
    Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
    07:25

    Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment

    Published on: March 1, 2024

    2.8K

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    8.4K
    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    8.4K
    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    5.7K
    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
    5.7K

    Articles linked to this work by shared authors, journal, and citation graph.

    NOD1 ligand FK565 promotes atherogenesis and accumulation of NOD1+ smooth muscle cells in atherosclerotic lesions.

    Atherosclerosis·2026

    [Retracted] Recent perspectives of electronic medical record systems (Review).

    Experimental and therapeutic medicine·2026

    [Retracted] Telemedicine in clinical setting (Review).

    Experimental and therapeutic medicine·2026

    Efgartigimod as an Add-on Therapy for Anti-IgLON5 Disease: A Case Report.

    Neurology and therapy·2026

    Whole-Exome Profiling of Epstein-Barr Virus-Positive Neuroendocrine Carcinoma of the Nasopharynx.

    Endocrine pathology·2026

    Incidence and disease spectrum of inherited metabolic diseases screened by tandem mass spectrometry in Huai'an from 2018 to 2024.

    Frontiers in pediatrics·2025

    Microbiome-based diagnostic biomarkers in pancreatic ductal adenocarcinoma: Current evidence and translational challenges (Review).

    Oncology letters·2026

    Pre-radiotherapy modified prognostic nutritional index predicts acute radiation enteritis in patients with cervical cancer undergoing radiotherapy: A retrospective study.

    Oncology letters·2026

    Efficacy and safety of ICI-based triple combination therapy for gene-negative advanced lung adenocarcinoma.

    Oncology letters·2026

    Primary cutaneous angiosarcoma of the scalp initially misdiagnosed as cellulitis in a 95-year-old Asian man: A case report.

    Oncology letters·2026

    Erratum: [Corrigendum] Long non-coding RNA CCAT2 functions as an oncogene in hepatocellular carcinoma, regulating cellular proliferation, migration and apoptosis.

    Oncology letters·2026

    Characterization of ZIC5 expression in esophageal squamous cell carcinoma and its association with patient survival.

    Oncology letters·2026

    Baseline Gustave Roussy Immune Score and Survival in Extensive-Stage Small-Cell Lung Cancer Treated with First-Line Chemoimmunotherapy.

    Cancer management and research·2026

    Prospective Assessment of Short-Term Response and Acute Toxicity With Accelerated Fractionation Radiotherapy Versus Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer.

    Cureus·2026

    Dissection of lymph node on longevity in breast and colorectal operation.

    Bioinformation·2026

    An Evaluation of the Effect of Opioid-Free Anesthesia on Early Quality of Recovery in Patients Undergoing Gynecological Cancer Surgeries: A Randomized Controlled Trial.

    Cureus·2026

    Engineered bacteria reverses tumor cuproptosis resistance via cancer-associated fibroblast reprogramming for enhanced immunotherapy.

    Materials today. Bio·2026

    Pan-Ras-In-1 triggers cell wall lysis to eradicate Staphylococcus aureus.

    iScience·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us